![Use of tumor markers to distinguish endometriosis-related ovarian neoplasms from ovarian endometrioma | International Journal of Gynecologic Cancer Use of tumor markers to distinguish endometriosis-related ovarian neoplasms from ovarian endometrioma | International Journal of Gynecologic Cancer](https://ijgc.bmj.com/content/ijgc/30/6/831/F2.large.jpg)
Use of tumor markers to distinguish endometriosis-related ovarian neoplasms from ovarian endometrioma | International Journal of Gynecologic Cancer
![Use of tumor markers to distinguish endometriosis-related ovarian neoplasms from ovarian endometrioma | International Journal of Gynecologic Cancer Use of tumor markers to distinguish endometriosis-related ovarian neoplasms from ovarian endometrioma | International Journal of Gynecologic Cancer](https://ijgc.bmj.com/sites/default/files/highwire/ijgc/30/6.cover-source.jpg)
Use of tumor markers to distinguish endometriosis-related ovarian neoplasms from ovarian endometrioma | International Journal of Gynecologic Cancer
The role of HE4 and CA125 in differentiation between malignant and non-malignant endometrial pathologies
![Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125 | Communications Biology Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125 | Communications Biology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs42003-020-01191-x/MediaObjects/42003_2020_1191_Fig1_HTML.png)